NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP)
CUSIP: 44975P103
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares)
- Shares outstanding
- 265,214,861
- Total 13F shares
- 14,193,703
- Share change
- -940,576
- Total reported value
- $17,600,522
- Put/Call ratio
- 10%
- Price per share
- $1.24
- Number of holders
- 27
- Value change
- -$1,644,775
- Number of buys
- 7
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 44975P103?
CUSIP 44975P103 identifies NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 44975P103:
Top shareholders of NBP - NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
13F
|
Company |
2.6%
|
6,909,220
|
$11,538,397 | — | 30 Jun 2024 | |
| Caligan Partners LP |
13F
|
Company |
1.3%
|
3,374,791
|
$5,635,901 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
1,379,352
|
$2,303,518 | — | 30 Jun 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.22%
|
576,600
|
$962,922 | — | 30 Jun 2024 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.21%
|
566,650
|
$946,306 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.18%
|
478,442
|
$798,998 | — | 30 Jun 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.1%
|
272,193
|
$455,000 | — | 30 Jun 2024 | |
| Exome Asset Management LLC |
13F
|
Company |
0.1%
|
271,400
|
$453,238 | — | 30 Jun 2024 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.09%
|
244,875
|
$453,019 | — | 30 Jun 2024 | |
| EDBI Pte Ltd |
13F
|
Company |
0.08%
|
222,136
|
$370,967 | — | 30 Jun 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.06%
|
162,580
|
$271,509 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.04%
|
102,961
|
$171,945 | — | 30 Jun 2024 | |
| Alberta Investment Management Corp |
13F
|
Company |
0.03%
|
74,723
|
$124,787 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
63,800
|
$106,546 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
58,358
|
$97,458 | — | 30 Jun 2024 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
57,933
|
$96,748 | — | 30 Jun 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
40,308
|
$67,314 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
38,708
|
$64,642 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
34,347
|
$57,359 | — | 30 Jun 2024 | |
| Mariner, LLC |
13F
|
Company |
0.01%
|
31,535
|
$52,663 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
31,066
|
$51,880 | — | 30 Jun 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
30,370
|
$50,718 | — | 30 Jun 2024 | |
| Donald L. Hagan, LLC |
13F
|
Company |
0.01%
|
30,000
|
$50,100 | — | 30 Jun 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.01%
|
17,876
|
$29,853 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
15,750
|
$26,303 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.01%
|
14,064
|
$23,488 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
13,880
|
$23,180 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0%
|
12,514
|
$20,898 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0%
|
7,684
|
$12,833 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
2,565
|
$4,284 | — | 30 Jun 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
1,367
|
$2,282 | — | 30 Jun 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,191
|
$1,988 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
568
|
$949 | — | 30 Jun 2024 | |
| Frazier Financial Advisors, LLC |
13F
|
Company |
0%
|
515
|
$861 | — | 30 Jun 2024 | |
| Catalyst Funds Management Pty Ltd |
13F
|
Company |
0%
|
90
|
$150 | — | 30 Jun 2024 | |
| GAMMA Investing LLC |
13F
|
Company |
0%
|
63
|
$105 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
50
|
$84 | — | 30 Jun 2024 |
Institutional Holders of NovaBridge Biosciences - Ordinary Shares, par value $0.0001 per share (Including Ordinary Shares Underlying American Depository Shares) (NBP) as of Q3 2024
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.